Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Search tool

Displaying 1 - 18 of 18

News

New EMCDDA miniguide on responding to opioid-related deaths highlights approaches and evidence that can help save lives

17.12.2021

Health and social responses to opioid-related deaths are explored in a new EMCDDA miniguide launched today. The resource is the ninth in a series of miniguides, making up the agency’s latest overview of actions and interventions to respond to the consequences of illicit drug use. Thousands of...

News

World AIDS Day: new EMCDDA miniguide on responding to drug-related infectious diseases

01.12.2021

Health and social responses to drug-related infectious diseases are explored today in a new EMCDDA miniguide, released to mark World AIDS Day. The resource is the eighth in a series of miniguides, making up the agency’s latest overview of actions and interventions to respond to the consequences of...

News

EMCDDA releases new European miniguides on responding to drug problems

18.10.2021

What are the most effective treatment options for cannabis problems? How to respond to new trends in cocaine use? How to help prevent the non-medical use of medicines? These are among the questions explored in a new collection of miniguides being launched today by the EU drugs agency (EMCDDA). The...

News

Six steps to improve the quality of drug services and systems — EMCDDA launches new practical manual for decision-makers

28.09.2021

Six steps to help improve the quality of drug services and systems in Europe are presented today in a new manual from the EU drugs agency (EMCDDA). Entitled Implementing quality standards for drug services and systems: a six-step guide to support quality assurance, the publication offers practical...

News

New report highlights public health and social risks posed by synthetic cannabinoids in Europe

09.09.2021

Synthetic cannabinoids come under the spotlight today in a new report released by the EU drugs agency (EMCDDA). Widely available across Europe and highly potent, these substances are placing some users at a ‘high risk of poisoning’, the agency warns. Synthetic cannabinoids are the largest group of...

News

International Overdose Awareness Day: EMCDDA answers key questions on drug-related deaths

31.08.2021

How many people die every year in Europe from a drug-related death? Are women and men affected equally? What substances are involved in these fatalities? These are some of the questions answered in the EMCDDA’s ‘Frequently asked questions (FAQs): drug overdose deaths in Europe’, published today to...

News

EMCDDA launches new resources to help European countries beat viral hepatitis

28.07.2021

On World Hepatitis Day, the EU drugs agency (EMCDDA) is launching a new set of resources to help European countries meet health targets to eliminate viral hepatitis. The resources, presented in an online toolkit, are part of a wider EMCDDA harm-reduction initiative supporting countries in their...

News

New EMCDDA report underlines need to scale up drug services in prisons

25.06.2021

Current insights and future challenges on drugs and prison in Europe are explored today in a major new study published by the EU drugs agency (EMCDDA)(1). Released on the eve of International day against drug abuse and illicit trafficking, the report, Prison and drugs in Europe: current and future...

News

EMCDDA releases third trendspotter study on COVID-19 and drugs

30.04.2021

In the third in its series of rapid ‘trendspotter’ studies, the EMCDDA explores the impact of COVID-19 on the drug situation and responses to it. Revisiting and reviewing findings from two studies in 2020 on the effects of the pandemic on drug use and services, the report identifies new trends and...

News

Maximising access to drug treatment while minimising diversion of medications — new EMCDDA report looks at striking the balance

11.02.2021

Opioid substitution treatment (OST) is a key evidence-based tool used to manage opioid dependence and improve related health and social consequences. Yet increasing reports of the diversion and misuse of the controlled drugs used in this treatment in Europe are a cause for concern. In a new report...

News

EMCDDA kicks off new wave of webinars for 2021

27.01.2021

The EMCDDA will be kicking off its 2021 programme of webinars on 3 February starting with the topic ‘Responding to drugs and homelessness: innovative approaches in Europe’. The link between long-term homelessness, problem drug use and alcohol dependence is well documented. As the COVID-19 pandemic...

News

EMCDDA publishes update on the implications of COVID-19 for people who use drugs and for drug service providers

25.03.2020

What specific risks are people who use drugs (PWUD) likely to face during the COVID-19 pandemic? What services will they need? How will professionals working with this group need to adapt on the frontline? These are among the questions raised in a new EMCDDA update published today. The update is...

News

Drug overdoses can be prevented — new resources released

30.08.2019

Latest estimates show that drug overdose deaths in Europe have risen for the fifth consecutive year, with a record 9 461 lives lost in 2017 (EU 28, Turkey and Norway). Reducing drug-related deaths is therefore a major public health challenge. Ahead of International Overdose Awareness Day, the EU...

News

Reitox Academy: Preventing and controlling infectious diseases among people who inject drugs

29.10.2013

Preventing and controlling infectious diseases among people who inject drugs is the focus of the latest EMCDDA Reitox Academy opening today in Sarajevo (Bosnia and Herzegovina). The two-day event gathers over 20 experts from five candidate and potential candidate countries to the EU (1). Building...

News

Neglecting the social needs of drug users can undermine chances of long-term recovery

15.10.2012

Over 1 million drug users in the European Union are estimated to be receiving some form of treatment for their drug problems every year. This reflects considerable investments since the 1990s when better access to treatment became a drug policy priority. But while treatment plays a significant role...

News

EMCDDA report presents latest evidence on heroin-assisted treatment for hard-to-treat opioid users

19.04.2012

A small population of chronic heroin users, once thought to be ‘untreatable’, is now benefiting from a novel type of therapy using medicinal heroin as the substitution drug. In a new report out today from the EU drugs agency (EMCDDA), experts describe the development as ‘an important clinical step...

News

Hepatitis C — the 'hidden epidemic'

04.02.2004

‘A hidden epidemic’ and ‘a major challenge to public health’ – this is how the EU drugs agency, the Lisbon-based EMCDDA, describes hepatitis C in the latest edition of its Drugs in focus series, out today. The agency says that over the past few years hepatitis C has emerged as a major threat to...

News

Drug injecting has a disproportionate impact on public health

19.07.2002

Drug injecting is rare and stigmatised by the public and, on the whole, by drug users themselves. But, despite this, it accounts for most of the severe health consequences of drug use in Europe today. So says the EU drugs agency, the EMCDDA, in the latest edition of its Drugs in focus series out...
Loading